Anixa Biosciences Inc SEC filings ANIX
Anixa Biosciences Inc has 983 filings in SEC EDGAR's recent list, going back to Jun 9, 1995. Its latest annual report, Form 10-K, was filed on Jan 12, 2026 for the period ended Oct 31, 2025. The latest quarterly report (Form 10-Q) was filed on Sep 9, 2026, covering the quarter ended Jul 31, 2026. The most recent current report (Form 8-K) was filed on Mar 11, 2026 (shareholder vote results, regulation fd disclosure). The company's fiscal year ends on October 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Sep 30, 2025 | — |
| CORRESP | Letter to the SEC | Sep 26, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 16, 2025 | — |
| EFFECT | Filing | Sep 19, 2022 | — |
| CORRESP | Letter to the SEC | Sep 15, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 14, 2022 | — |
| DEL AM | Filing | Sep 12, 2022 | — |
| EFFECT | Filing | Jun 21, 2019 | — |
| CORRESP | Letter to the SEC | Jun 19, 2019 | — |
| UPLOAD | Letter from the SEC | Jun 18, 2019 | — |
| CT ORDER | Filing | Feb 15, 2018 | — |
| EFFECT | Filing | Oct 26, 2017 | — |
| CORRESP | Letter to the SEC | Oct 24, 2017 | — |
| UPLOAD | Letter from the SEC | Oct 23, 2017 | — |
| EFFECT | Filing | Apr 10, 2017 | — |
| CORRESP | Letter to the SEC | Apr 6, 2017 | — |
| UPLOAD | Letter from the SEC | Apr 3, 2017 | — |
| RW | Request withdrawal of s-1 file no. 333-215799 | Mar 27, 2017 | — |
| CT ORDER | Filing | Feb 1, 2017 | — |
| EFFECT | Filing | Feb 2, 2016 | — |
| EFFECT | Filing | Sep 18, 2015 | — |
| CORRESP | Letter to the SEC | Sep 16, 2015 | — |
| UPLOAD | Letter from the SEC | Sep 10, 2015 | — |
| CERTNAS | Auto-generated paper document | Jul 9, 2015 | — |
| 8-A12B | Form 8-a | Jul 9, 2015 | — |
| EFFECT | Filing | Mar 19, 2015 | — |
| AW | Form aw | Mar 18, 2015 | — |
| EFFECT | Filing | Mar 13, 2015 | — |
| CORRESP | Letter to the SEC | Mar 11, 2015 | — |
| CORRESP | Letter to the SEC | Mar 3, 2015 | — |
| UPLOAD | Letter from the SEC | Dec 16, 2014 | — |
| UPLOAD | Letter from the SEC | Jun 17, 2014 | — |
| CORRESP | Letter to the SEC | Jun 16, 2014 | — |
| PRER14A | Revised preliminary proxy statement | Jun 16, 2014 | — |
| UPLOAD | Letter from the SEC | Jun 13, 2014 | — |
| EFFECT | Filing | May 8, 2014 | — |
| CORRESP | Letter to the SEC | May 6, 2014 | — |
| EFFECT | Filing | Apr 25, 2014 | — |
| CORRESP | Letter to the SEC | Apr 23, 2014 | — |
| CORRESP | Letter to the SEC | Apr 17, 2014 | — |
| UPLOAD | Letter from the SEC | Apr 15, 2014 | — |
| CORRESP | Letter to the SEC | Apr 9, 2014 | — |
| UPLOAD | Letter from the SEC | Apr 7, 2014 | — |
| CORRESP | Letter to the SEC | Mar 28, 2014 | — |
| CORRESP | Letter to the SEC | Mar 13, 2014 | — |
| CORRESP | Letter to the SEC | Mar 13, 2014 | — |
| UPLOAD | Letter from the SEC | Mar 6, 2014 | — |
| UPLOAD | Letter from the SEC | Mar 6, 2014 | — |
| EFFECT | Filing | Feb 5, 2014 | — |
| AW | Form aw | Feb 3, 2014 | — |
| D | Filing | Nov 22, 2013 | — |
| EFFECT | Filing | Jun 14, 2013 | — |
| CORRESP | Letter to the SEC | Jun 14, 2013 | — |
| UPLOAD | Letter from the SEC | Jun 11, 2013 | — |
| CORRESP | Letter to the SEC | May 28, 2013 | — |
| UPLOAD | Letter from the SEC | May 21, 2013 | — |
| CT ORDER | Filing | May 3, 2013 | — |
| D | Filing | May 2, 2013 | — |
| D | Filing | Feb 4, 2013 | — |
| CT ORDER | Filing | Nov 15, 2012 | — |
| D | Filing | Sep 18, 2012 | — |
| CT ORDER | Filing | Jan 18, 2012 | — |
| D | Filing | Feb 16, 2011 | — |
| NT 10-K | Copytele, inc. nt 10-k | Jan 31, 2011 | Oct 31, 2010 |
| CORRESP | Letter to the SEC | Sep 29, 2010 | — |
| UPLOAD | Letter from the SEC | Sep 28, 2010 | — |
| UPLOAD | Letter from the SEC | Jul 27, 2010 | — |
| CT ORDER | Filing | Jul 27, 2010 | — |
| CORRESP | Letter to the SEC | Jun 29, 2010 | — |
| UPLOAD | Letter from the SEC | Jun 4, 2010 | — |
| DFAN14A | Filing | Jun 1, 2010 | — |
| PREC14A | Filing | May 28, 2010 | — |
| CORRESP | Letter to the SEC | May 13, 2010 | — |
| UPLOAD | Letter from the SEC | Apr 27, 2010 | — |
| CORRESP | Letter to the SEC | Apr 12, 2010 | — |
| UPLOAD | Letter from the SEC | Mar 31, 2010 | — |
| CORRESP | Letter to the SEC | Mar 10, 2010 | — |
| UPLOAD | Letter from the SEC | Feb 23, 2010 | — |
| NT 10-Q | Copytele, inc. nt 10-q | Jun 10, 2009 | Apr 30, 2009 |
| NT 10-K | Copytele, inc. nt 10-k | Jan 15, 2009 | Oct 31, 2008 |
| NT 10-Q | Copytele, inc. nt 10-q | Sep 10, 2008 | Jul 31, 2008 |
| UPLOAD | Letter from the SEC | Mar 13, 2008 | — |
| NT 10-Q | Copytele, inc. nt 10-q | Mar 12, 2008 | Jan 31, 2008 |
| CORRESP | Letter to the SEC | Mar 5, 2008 | — |
| UPLOAD | Letter from the SEC | Feb 20, 2008 | — |
| NT 10-K | Copytele, inc. nt 10-k | Jan 15, 2008 | Oct 31, 2007 |
| NT 10-Q | Copytele, inc. nt 10-q | Sep 11, 2007 | Jul 31, 2007 |
| NT 10-K | Copytele, inc. nt 10-k | Jan 17, 2006 | Oct 31, 2005 |
| UPLOAD | Letter from the SEC | May 2, 2005 | — |
| CORRESP | Letter to the SEC | Apr 15, 2005 | — |
| UPLOAD | Letter from the SEC | Apr 1, 2005 | — |
| NT 10-K | Copytele nt-10-k (12b-25) | Jan 18, 2005 | Oct 31, 2004 |
| NT 10-K | Copytele, inc. nt 10-k | Jan 29, 2003 | Oct 31, 2002 |
| 10-K405 | Year end | Jan 29, 1999 | Oct 31, 1998 |
| 10-K405 | Year end | Jan 29, 1998 | Oct 31, 1997 |
| 10-K405/A | Amendment no 1 to form 10-k | Jan 31, 1997 | Oct 31, 1996 |
| 10-K405 | Form 10-k | Jan 29, 1997 | Oct 31, 1996 |
| 10-C | Report by issuer of securities quoted on nasdaq | Jun 19, 1996 | Jun 17, 1996 |
| 10-K405 | Copytele form 10-k for period ending 10/31/95 | Jan 29, 1996 | Oct 31, 1995 |
Showing 99 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ANIX (Nasdaq)
- Fiscal year ends
- October 31
- Incorporated in
- DE
- Headquarters
- San Jose, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 715446
- Former names
- ITUS Corp (until Sep 27, 2018); COPYTELE INC (until Aug 27, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.